PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes

Genes and Immunity

Volumn 15, Issue 8, 2014, Pages 556-561

  Saeed, M ^a   Beggs, M L ^a   Walker, P D ^a   Larsen, C P ^a  

^a Nephropath ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQA1 ANTIGEN; PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOLIPASE A2 RECEPTOR 1; UNCLASSIFIED DRUG; HLA DQ ANTIGEN; HLA-DQA1 ANTIGEN; PLA2R1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOGENICITY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MULTIFACTOR DIMENSIONALITY REDUCTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AFRICAN AMERICAN; AGED; CAUCASIAN; EPISTASIS; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; STATISTICAL MODEL;

ADULT; AFRICAN AMERICANS; AGED; ALLELES; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, MEMBRANOUS; HAPLOTYPES; HLA-DQ ALPHA-CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84927130766     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.50     Document Type: Article

References (20)

1. Beck LH, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.
2. Qin W, Beck Jr LH, Zeng C, Chen Z, Li S, Zuo K et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1137-1143.
3. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor (PLA2R1) staining in renal biopsies. Mod Pathol 2013; 26: 709-715.
4. Hoxha E, Kneissler U, Stege G, Zahner G, Thiele I, Panzer U et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 2012; 82: 797-804.
5. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L et al. Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364: 616-626.
6. Liu YH, Chen CH, Chen SY, Lin YJ, Liao WL, Tsai CH et al. Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan. J Biomed Sci. 2010; 17: 81.
7. Kim S, Chin HJ, Na KY, Oh J, Chung W, Noh JW et al. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy. Nephron Clin Pract 2011; 117: c253-c258.
8. Coenen MJ, Hofstra JM, Debiec H, Stanescu HC, Medlar AJ, Stengel B et al. Phospholipase A2 Receptor (PLA2R1) Sequence Variants in Idiopathic Membranous Nephropathy. J Am Soc Nephrol 2013; 24: 677-683.
9. Lv J, Hou W, Zhou X, Liu G, Zhou F, Zhao N et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with Anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol 2013; 24: 1323-1329.
10. Morris AP. Transethnic meta-analysis of genomewide association studies. Genet Epidemiol 2011; 35: 809-822.
11. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003; 24: 150-157.
12. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Gent 2006; 38: 209-213.
13. Pulit SL, Voight BF, de Bakker PIW. Multiethnic genetic association studies improve power for locus discovery. PLoS ONE 2010; 5: e12600.
14. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-424.
15. Larsen CP, Beggs ML, Saeed M, Walker PD. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. J Am Soc Nephrol 2013; 24: 722-725.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
17. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
18. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003; 19: 376-382.
19. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445.
20. Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 1988; 4: 181-186.